Physician
Hematology
Dr. Brian F. Issell, MD
|
|
Give Review
Doctor Brian F. Issell, MD is an expert in the field of Hematology. He researched medicine at University of Otago School of Medicine. He received awards:"Whos Who in Medicine and Healthcare". Brian F. Issell is a published doctor. He published 58 publications, including: 'Protection against chemotherapy toxicity by IV hyperalimentation.'
Publications
- WITHDRAWN: Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting.
- Complementary and Alternative Medicine Use and Breast Cancer Prognosis: A Pooled Analysis of Four Population-Based Studies of Breast Cancer Survivors.
- Factors affecting survival among women with breast Cancer in Hawaii.
- S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach.
- Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
- Breast Cancer treatment among women of different ethnicity in Hawaii.
- Exercise and side effects among 749 patients during and after treatment for Cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.
- Exploratory Analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected.
- Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid Cancers: Southwest Oncology, Group Study 8940.
- Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting.
- Prevalence of complementary and alternative medicine use in Cancer patients during treatment.
- Influences of ethnicity, treatment, and comorbidity on breast Cancer survival in Hawaii.
- The use of Breast conserving surgery: linking insurance claims with tumor registry data.
- A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
- Carminomycin. A new anthracycline Analog in the treatment of advanced breast cancer.
- Phase II study of VP16-213 (etoposide) in refractory metastatic Breast carcinoma.
- Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.
- A phase I and clinical pharmacology study of intravenously administered carminomycin in Cancer patients in the United States.
- The podophyllotoxin derivatives VP16-213 and VM26.
- Amsacrine (AMSA).
- Treatment of advanced adenocarcinoma of the Lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
- The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
- Disposition of orally administered 14C-prednimustine in Cancer patients.
- Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the Lung with etoposide and cisplatin.
- Usefulness of the human tumor colony forming assay for new drug development.
- Mezlocillin for treatment of infections in Cancer patients.
- Mitomycin C intravesical therapy in noninvasive bladder Cancer after failure on thiotepa.
- The human tumor colony-forming chemosensitivity assay: a biological and clinical review.
- New platinum complexes in clinical trials.
- Zinostatin and doxorubicin. A combination phase I study.
- Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck Cancer.
- Radioimmunoassay for etoposide and teniposide.
- Clinical pharmacology of intraperitoneal cisplatin.
- Amsacrine (AMSA)--a clinical review.
- Mitomycin: ten years after approval for marketing.
- Cell-mediated inhibition of tumor colony formation in agarose by resting and interleukin 2-stimulated human lymphocytes.
- Prospects for immunotoxin therapy in Cancer.
- Multicenter Phase II trial of etoposide in refractory small cell lung Cancer.
- Clinical pharmacology of mezlocillin.
- Etoposide (VP-16-213).
- Cisplatin (cis-diamminedichloroplatinum II).
- Maytansine.
- Combination chemoimmunotherapy for extensive non-oat cell lung Cancer.
- Continuous infusion tobramycin combined with carbenicillin for infections in Cancer patients.
- Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the Lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
- Zinostatin (neocarzinostatin).
- Protection against chemotherapy toxicity by IV hyperalimentation.
- Pharmacokinetics of tallysomycin and bleomycin in the beagle dog.
- Availability of clinical trials for Hawaii Cancer patients.
- Impact of a culturally appropriate intervention on Breast and cervical screening among native Hawaiian women.
- Use of complementary and alternative medicine in Hawaii Cancer patients.
- Participatory research in a Native Hawaiian community. The Wai'anae Cancer Research Project.
- Barriers to mammography in a low income, multiethnic clinic population.
- A breast and cervical Cancer project in a native Hawaiian community: Wai'anae Cancer research project.
- Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma.
- Serum zinc levels in lung Cancer patients.
- Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting.
Schools
University Of Otago Dunedin Medical School
University Otago Otago Hospital
MD Anderson Hospital
Conditions Treated
- Anal and Rectal Cancer
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
University of Texas MD Anderson Cancer Center -
University of Otago School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Clayton D. Chong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared D. Acoba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert T. Jim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niranjan T. Rajdev, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer F. Carney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quintin L. Uy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dipak Ghelani, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keola K. Beale, MD |